JP2015526453A5 - - Google Patents

Download PDF

Info

Publication number
JP2015526453A5
JP2015526453A5 JP2015527913A JP2015527913A JP2015526453A5 JP 2015526453 A5 JP2015526453 A5 JP 2015526453A5 JP 2015527913 A JP2015527913 A JP 2015527913A JP 2015527913 A JP2015527913 A JP 2015527913A JP 2015526453 A5 JP2015526453 A5 JP 2015526453A5
Authority
JP
Japan
Prior art keywords
alkyl
group
phenyl
cycloalkyl
ring
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015527913A
Other languages
English (en)
Japanese (ja)
Other versions
JP6319747B2 (ja
JP2015526453A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2013/067425 external-priority patent/WO2014029830A1/en
Publication of JP2015526453A publication Critical patent/JP2015526453A/ja
Publication of JP2015526453A5 publication Critical patent/JP2015526453A5/ja
Application granted granted Critical
Publication of JP6319747B2 publication Critical patent/JP6319747B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015527913A 2012-08-23 2013-08-22 置換4−ピリドン及びそれらの好中球エラスターゼ活性阻害薬としての使用 Active JP6319747B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12181542 2012-08-23
EP12181542.7 2012-08-23
PCT/EP2013/067425 WO2014029830A1 (en) 2012-08-23 2013-08-22 Substituted 4-pyridones and their use as inhibitors of neutrophil elastase activity

Publications (3)

Publication Number Publication Date
JP2015526453A JP2015526453A (ja) 2015-09-10
JP2015526453A5 true JP2015526453A5 (https=) 2016-10-13
JP6319747B2 JP6319747B2 (ja) 2018-05-09

Family

ID=46963420

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015527913A Active JP6319747B2 (ja) 2012-08-23 2013-08-22 置換4−ピリドン及びそれらの好中球エラスターゼ活性阻害薬としての使用

Country Status (7)

Country Link
US (2) US20140057926A1 (https=)
EP (1) EP2888242B1 (https=)
JP (1) JP6319747B2 (https=)
AR (1) AR092205A1 (https=)
TW (1) TW201422586A (https=)
UY (1) UY34989A (https=)
WO (1) WO2014029830A1 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9458113B2 (en) 2014-07-31 2016-10-04 Boehringer Ingelheim International Gmbh Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity
US9290457B2 (en) 2014-07-31 2016-03-22 Boehringer Ingelheim International Gmbh Substituted dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity
US9440930B2 (en) 2014-07-31 2016-09-13 Boehringer Ingelheim International Gmbh Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity
US9475779B2 (en) 2014-07-31 2016-10-25 Boehringer Ingelheim International Gmbh Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity
US9657015B2 (en) 2014-07-31 2017-05-23 Boehringer Ingelheim International Gmbh Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity
UY36547A (es) 2015-02-05 2016-06-01 Bayer Cropscience Ag Derivados heterocíclicos condensados bicíclicos sustituidos por 2-(het)arilo como pesticidas
TW201718514A (zh) 2015-08-07 2017-06-01 拜耳作物科學股份有限公司 作為殺蟲劑之經2-(雜)芳基取代之稠合雜環衍生物
WO2018211442A1 (en) 2017-05-18 2018-11-22 Pi Industries Ltd. Formimidamidine compounds useful against phytopathogenic microorganisms
EP3638681A1 (en) * 2017-06-13 2020-04-22 Quretech Bio AB Ring-fused thiazolino 2-pyridones, methods for preparation thereof and their use in the treatment and/or prevention of a disease involving gram-positive bacteria
JP7672641B2 (ja) 2019-09-17 2025-05-08 メレオ バイオファーマ 4 リミテッド 移植片拒絶反応、閉塞性細気管支炎症候群、及び移植片対宿主病の治療に使用するためのアルベレスタット
IL297211B2 (en) 2020-04-16 2025-12-01 Mereo Biopharma 4 Ltd Methods involving neutrophil elastase inhibitor alvelestat for treating respiratory disease mediated by alpha-1 antitrypsin deficiency
KR20240090272A (ko) 2021-10-20 2024-06-21 메레오 바이오파마 4 리미티드 섬유화 치료에 사용하기 위한 호중구 엘라스테이스 억제제
CN119977990B (zh) * 2024-12-30 2026-03-31 海南师范大学 一种海洋真菌来源的杀虫杀菌化合物及其制备方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4844732A (en) * 1985-10-24 1989-07-04 Daicel Chemical Industries Ltd. Pyridine-3-carboxamide derivatives
US7211595B2 (en) 2000-11-30 2007-05-01 Abbott Laboratories Farnesyltransferase inhibitors
TW200500341A (en) 2002-11-12 2005-01-01 Astrazeneca Ab Novel compounds
SE0302487D0 (sv) 2003-09-18 2003-09-18 Astrazeneca Ab Novel compounds
SE0302486D0 (sv) 2003-09-18 2003-09-18 Astrazeneca Ab Novel compounds
TW200700392A (en) 2005-03-16 2007-01-01 Astrazeneca Ab Novel compounds
US20090325924A1 (en) 2005-06-30 2009-12-31 Stuart Edward GPCR Agonists
ITMI20060285A1 (it) 2006-02-16 2007-08-17 Polimeri Europa Spa Procdedimento perfezionato per la preparazione di radicali nitrosilici stabili
TW200808763A (en) 2006-05-08 2008-02-16 Astrazeneca Ab Novel compounds I
TW200808771A (en) 2006-05-08 2008-02-16 Astrazeneca Ab Novel compounds II
WO2009058076A1 (en) 2007-11-02 2009-05-07 Astrazeneca Ab 2-pyrazinone derivatives and their use as inhibitors of neutrophile elastase
EP2217591A4 (en) 2007-11-06 2011-10-26 Astrazeneca Ab CERTAIN 2-PYRAZINONE DERIVATIVES AND THEIR USE AS NEUTROPHILES ELASTASE INHIBITORS
BRPI0906444B8 (pt) * 2008-01-23 2021-05-25 Bristol Myers Squibb Co compostos de 4-piridinona, composição farmacêutica que os compreende, bem como uso dos mesmos
EP2307370B1 (en) 2008-06-23 2012-01-04 Basf Se Sulfoximinamide compounds for combating animal pests
TW201036957A (en) 2009-02-20 2010-10-16 Astrazeneca Ab Novel salt 628
EP2261211A1 (en) 2009-05-20 2010-12-15 Université de Lille 2 Droit et Santé 1,4-dihydropyridine derivatives and their uses
AU2010302420B2 (en) 2009-10-02 2013-07-04 Astrazeneca Ab 2-pyridone compounds used as inhibitors of neutrophil elastase
WO2011110852A1 (en) 2010-03-10 2011-09-15 Astrazeneca Ab Polymorphic forms of 6- [2- (4 -cyanophenyl) - 2h - pyrazol - 3 - yl] - 5 -methyl - 3 - oxo - 4 - (trifluoromethyl - phenyl) 3,4-dihydropyrazine-2-carboxylic acid ethylamide

Similar Documents

Publication Publication Date Title
JP2015526453A5 (https=)
JP2015526455A5 (https=)
JP2016516020A5 (https=)
JP2016511262A5 (https=)
JP2015526454A5 (https=)
JP2010511721A5 (https=)
JP2010501478A5 (https=)
JP2016518328A5 (https=)
EA201650029A1 (ru) Пиразолопиридины и пиразолопиримидины
JP2017504635A5 (https=)
JP2014511892A5 (https=)
JP2016520618A5 (https=)
JP2016515561A5 (https=)
JP2015504081A5 (https=)
JP2016507575A5 (https=)
JP2017509611A5 (https=)
JP2015514808A5 (https=)
JP2009542716A5 (https=)
RU2016110096A (ru) Новое хинолин-замещенное соединение
JP2012508252A5 (https=)
JP2016505614A5 (https=)
HRP20171040T1 (hr) Supstituirani biciklički dihidropirimidinoni i njihova uporaba za inhibiranje djelovanja elastaze neutrofila
JP2016532677A5 (https=)
JP2016510784A5 (https=)
JP2016515110A5 (https=)